SCHEMBL12735990

SCHEMBL12735990

CN1C(C=O)COC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12140443 1.00 — —
SCHEMBL10578538 1.00 — —
SCHEMBL12620348 0.77 — —
SCHEMBL8280629 0.74 — —
SCHEMBL15925932 0.74 SPHK1 (0.32) —
SCHEMBL158240 0.72 CYP1A2 (0.31) —
SCHEMBL1503804 0.72 CYP1A2 (0.31) —
SCHEMBL12088012 0.71 — —
SCHEMBL17305957 0.71 — —
SCHEMBL5018437 0.71 SPHK1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 — — EP disclosed
US-20170097567-A1 METHOD FOR PRODUCING POLYMER SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-06 — — US disclosed
US-20160229940-A1 POLYMER, RESIST COMPOSITION, AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-08-11 — — US disclosed
US-9133097-B2 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2015-09-15 — — US disclosed
US-20150051207-A1 USE OF UNSATURATED SPHINGOSINE COMPOUNDS AS CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-02-19 — — US disclosed
US-8741967-B2 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2014-06-03 — — US disclosed
US-20110098317-A1 USE OF UNSATURATED SPHINGOSINE COMPOUNDS AS CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2011-04-28 — — US disclosed
Send feedback